ELEVATEBIO
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's most innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.
ELEVATEBIO
Industry:
Biotechnology
Founded:
2017-01-01
Status:
Active
Contact:
617-433-2600
Email Addresses:
[email protected]
Total Funding:
845 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Biofourmis
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Catamaran Bio
Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-27 | Life Edit | Life Edit acquired by ElevateBio | N/A |
Investors List
EDBI
EDBI investment in Series C - ElevateBio
Emerson Collective
Emerson Collective investment in Series C - ElevateBio
Samsara BioCapital
Samsara BioCapital investment in Series C - ElevateBio
Surveyor Capital
Surveyor Capital investment in Series C - ElevateBio
ITOCHU Corporation
ITOCHU Corporation investment in Series C - ElevateBio
Redmile Group
Redmile Group investment in Series C - ElevateBio
Vertex Ventures
Vertex Ventures investment in Series C - ElevateBio
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - ElevateBio
Invus
Invus investment in Series C - ElevateBio
F2 Ventures
F2 Ventures investment in Series C - ElevateBio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | AlloVir | ElevateBio investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2021-06-23 | Abata Therapeutics | ElevateBio investment in Series A - Abata Therapeutics | 95 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | ElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development |
| 2020-03-05 | ElevateBio Appoints Kareem Reda as Chief Business Officer |
More informations about "ElevateBio"
ElevateBio 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ElevateBio. Use the PitchBook Platform to explore the full profile.See details»
ElevateBio - Crunchbase Company Profile & Funding
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.See details»
ElevateBio: 2025 CNBC Disruptor 50
Jun 10, 2025 ElevateBio uses CRISPR gene editing technology to develop treatments for diseases from cancer to multiple sclerosis, diabetes, and Huntington's Disease.See details»
ElevateBio - LinkedIn
ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, …See details»
ElevateBio - VentureRadar
"ElevateBio, LLC, is a Cambridge-based biotechnology holding company, established to create and operate a broad portfolio of cell and gene therapy companies through partnerships with …See details»
ElevateBio - Cell and Gene
ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come. The company’s integrated technologies model offers turnkey scale and …See details»
ElevateBio LLC - Drug pipelines, Patents, Clinical trials
May 7, 2025 Explore ElevateBio LLC with its drug pipeline, therapeutic area, technology platform, 112 news, Disease Domain:Nervous System Diseases, Immune System Diseases, Endocrinology and Metabolic Disease, Technology …See details»
About Us - ElevateBio
ElevateBio is a technology-driven cell and gene therapy company, accelerating access to the cutting-edge technologies and expertise to change the future of medicine. Our integrated technologies model offers turnkey scale and …See details»
ElevateBio - Company info. interviews, news
Jan 12, 2024 ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built …See details»
ElevateBio BaseCamp Achieves ICMC™ Certification for …
2 days ago ICMC certification delivered by Dark Horse Consulting certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. …See details»
ElevateBio Company Profile - Office Locations, Competitors ... - Craft
ElevateBio has 5 employees across 2 locations and $845 m in total funding,. See insights on ElevateBio including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
ElevateBio proposes centralized model for cell & gene startups
May 15, 2019 Neither a CDMO nor an end-user, ElevateBio is looking to change the paradigm in cell and gene therapy development through it’s a centralized R&D and manufacturing model. …See details»
ElevateBio | ISPE | International Society for Pharmaceutical …
ElevateBio is a technology-driven cell and gene therapy company, accelerating access to the cutting-edge technologies and expertise to change the future of medicine. Our integrated …See details»
Our Story - ElevateBio
Since our inception, we have aimed to be the dominant engine inside the world’s greatest scientific advancements harnessing human cells and genes to alter disease.See details»
What Is the Brief History of ElevateBio Company?
Jul 24, 2025 The ElevateBio history is marked by strategic leadership and significant investment. The company's founders brought extensive experience from the biotechnology and …See details»
Our Ecosystem - ElevateBio
ElevateBio definitely has a strong edge with our talent, technology platform and partnerships. With all of that combined, we’re not only helping our own internal pipelines, but also external …See details»
ElevateBio Formed to Create Portfolio of Cell & Gene
May 26, 2019 – ElevateBio to leverage its fully integrated, company building bench-to-bedside capabilities exclusively focused on cell and gene therapies – ElevateBio’s BaseCamp, an …See details»
ElevateBio BaseCamp Achieves ICMCâ„¢ Certification for ... - BioSpace
19 hours ago ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company applies its enabling …See details»
Partner with Us - ElevateBio
ElevateBio’s breadth of expertise and network of capabilities can power the creation of your novel cell and gene therapies. We have assembled top talent and technical know-how, capabilities …See details»
Life Sciences Future 2025 - ElevateBio
ElevateBio Named to the 2025 CNBC Disruptor 50 List This is the fourth time in five years we were recognized as one of the most innovative private companies.See details»